mRNA新冠疫苗接种后自身免疫性皮肤与结缔组织病风险
韩国全国性人群研究纳入3,838,120名mRNA新冠疫苗接种者与3,834,804名匹配未感染对照,比较自身免疫性皮肤及结缔组织病风险。多数疾病风险在接种者中未显著升高,且按年龄、性别、疫苗类型及交叉接种状态结果相当。作者指出罕见结局因统计效能有限需谨慎解读。
要点
- 斑秃、全秃、原发性瘢痕性脱发、银屑病、白癜风等风险未显著高于对照。
- ANCA相关血管炎、结节病、白塞病、炎症性肠病、类风湿关节炎等风险未显著升高。
- 按年龄、性别、mRNA疫苗类型及交叉接种状态,风险相当。
核心结论
- 这些发现提示大多数自身免疫性结缔组织病与mRNA新冠疫苗接种无显著风险增加关联。
- 作者指出罕见结局因统计效能有限,解读结果时需谨慎。
研究设计与样本
- 韩国全国性人群研究,纳入2020年9月8日至2021年12月31日接种疫苗者。
- 历史大流行前对照按年龄和性别1:1匹配。
- 共纳入3,838,120名疫苗接种者和3,834,804名无COVID-19证据的对照。
主要发现
- 斑秃、全秃、原发性瘢痕性脱发、银屑病、白癜风、ANCA相关血管炎、结节病、白塞病、克罗恩病、溃疡性结肠炎风险在接种者中未显著高于对照。
- 类风湿关节炎、系统性红斑狼疮、系统性硬化症、干燥综合征、强直性脊柱炎、皮肌炎/多肌炎、大疱性类天疱疮风险在接种者中未显著高于对照。
- 按年龄、性别、mRNA疫苗类型和交叉接种状态,风险相当。
临床怎么用
- 原文未据此给出推荐。
局限性
- 可能存在选择偏倚和残余混杂。
- 罕见结局因统计效能有限,解读结果时需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Data on the association between the development of autoimmune diseases and COVID-19 vaccination are limited. OBJECTIVE: To investigate the incidence and risk of autoimmune connective tissue disorders following mRNA-based COVID-19 vaccination. METHODS: This nationwide population-based study was conducted in South Korea. Individuals who received vaccination between September 8, 2020-December 31, 2021, were identified. Historical prepandemic controls were matched for age and sex in 1:1 ratio. The incidence rate and risk of disease outcomes were compared. RESULTS: A total of 3,838,120 vaccinated individuals and 3,834,804 controls without evidence of COVID-19 were included. The risk of alopecia areata, alopecia totalis, primary cicatricial alopecia, psoriasis, vitiligo, anti-neutrophil cytoplasmic antibody-associated vasculitis, sarcoidosis, Behcet disease, Crohn disease, ulcerative colitis, rheumatoid arthritis, systemic lupus erythematosus, systemic sclerosis, Sjogren syndrome, ankylosing spondylitis, dermato/polymyositis, and bullous pemphigoid was not significantly higher in vaccinated individuals than in controls. The risk was comparable according to age, sex, type of mRNA-based vaccine, and cross-vaccination status. LIMITATIONS: Possible selection bias and residual confounders. CONCLUSION: These findings suggest that most autoimmune connective tissue disorders are not associated with a significant increase in risk. However, caution is necessary when interpreting results for rare outcomes due to limited statistical power.
引用
- Ju HJ, Lee JY, Han JH, et al. Risk of autoimmune skin and connective tissue disorders after mRNA-based COVID-19 vaccination. J Am Acad Dermatol. 2023. PMID: 37187424. doi:10.1016/j.jaad.2023.05.017
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。